相关实验视频
Updated: Feb 12, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
20.2K
关于心力衰竭患者的存活和心脏功能改善的长期回顾性研究 心脏动患者用射频废除治疗心脏衰竭患者
Lin He1, Min He2, Pengyu Zhong1
1Department of Cardiology, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital.
Kardiologiia
|February 11, 2026
概括
射频导管切除可显著改善心力衰竭 (HF) 和心房动 (AF) 患者的存活率和心脏功能. 这种程序减少了死亡率,住院和AF复发与单独的医疗治疗相比.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭管理的管理
背景情况:
- 心房动 (AF) 和心力衰竭 (HF) 经常同时存在,使预后恶化.
- 目前的管理通常涉及医疗治疗,但其在改善这一群体的存活率和心脏功能方面的长期有效性是有争议的.
研究的目的:
- 为了比较射频导管切除与保守医学治疗对HF和AF患者的生存,心脏功能和临床结果的长期影响.
主要方法:
- 对328名患有HF和AF的患者 (2015-2020) 的回顾性分析.
- 射频剥离 (n=165) 和医疗治疗 (n=163) 组之间的比较.
- 主要终点:全因死亡率;次要终点:心血管死亡,高风险住院,LVEF改善,AF复发.
- 随访:中位数为45个月;分析:卡普兰-梅尔,考克斯回归.
主要成果:
- 射频除组显示出更高的5年生存率 (p=0.021) 和更低的心血管死亡率 (p=0.024).
- 切除显著减少了HF住院 (p=0.008) 和AF复发 (68.5%对比21.5%在60个月,p<0.001).
- 12个月后,左心室喷射分数 (LVEF) 在废除组增加了8.3%,而在医疗组增加了0.4% (p<0.001).
结论:
- 射频导管切除是HF和AF患者的优越治疗选择.
- 切除改善了长期生存,心脏功能和生活质量,同时减少了住院治疗.
- 射频除是一种独立的保护因素,可以防止该患者队列中因任何原因的死亡.
更多相关视频
相关概念视频
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Amyloid Fibrils
12.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K

